BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 27055430)

  • 21. X-Linked Lymphoproliferative Syndrome: A Spectrum of Clinical and Immunological Profile and Novel Pathogenic Variants from Chandigarh, India.
    Jindal AK; Mondal S; Sil A; Rawat A; Chawla S; Tyagi R; Sudhakar M; Banday AZ; Suri D; Vignesh P; Dhaliwal M; Sharma S; Rikhi R; Saka R; Sharma R; Chatterjee D; Sreedharanunni S; Uppuluri R; Raj R; Singh S
    Int Arch Allergy Immunol; 2024; 185(4):370-381. PubMed ID: 38194943
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A new SH2D1A mutation in a female adult XLP disease with hemophagocytic lymphohistiocytosis and NK-cell leukemia.
    Liang JH; Zhu HY; Xu DM; Wang L; Wang Y; Qiao C; Wu YJ; Wang R; Li JY; Xu W
    Ann Hematol; 2019 Dec; 98(12):2829-2831. PubMed ID: 31758261
    [No Abstract]   [Full Text] [Related]  

  • 23. Rapid detection of intracellular SH2D1A protein in cytotoxic lymphocytes from patients with X-linked lymphoproliferative disease and their family members.
    Tabata Y; Villanueva J; Lee SM; Zhang K; Kanegane H; Miyawaki T; Sumegi J; Filipovich AH
    Blood; 2005 Apr; 105(8):3066-71. PubMed ID: 15632210
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Severe hemorrhagic coagulopathy with hemophagocytic lymphohistiocytosis secondary to Epstein-Barr virus-associated T-cell lymphoproliferative disorder.
    Nawathe PA; Ravindranath TM; Satwani P; Baird JS
    Pediatr Crit Care Med; 2013 May; 14(4):e176-81. PubMed ID: 23439459
    [TBL] [Abstract][Full Text] [Related]  

  • 25. X-linked lymphoproliferative syndrome presenting with systemic lymphocytic vasculitis.
    Kanegane H; Ito Y; Ohshima K; Shichijo T; Tomimasu K; Nomura K; Futatani T; Sumazaki R; Miyawaki T
    Am J Hematol; 2005 Feb; 78(2):130-3. PubMed ID: 15682426
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Exon skipping caused by a complex structural variation in SH2D1A resulted in X-linked lymphoproliferative syndrome type 1.
    Wu L; Yang F; Wang J; Yang F; Liang M; Yang H
    Mol Genet Genomic Med; 2022 Mar; 10(3):e1873. PubMed ID: 35092357
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hemophagocytic lymphohistiocytosis due to germline mutations in SH2D1A, the X-linked lymphoproliferative disease gene.
    Arico M; Imashuku S; Clementi R; Hibi S; Teramura T; Danesino C; Haber DA; Nichols KE
    Blood; 2001 Feb; 97(4):1131-3. PubMed ID: 11159547
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [The significance of pedigree genetic screening and rapid immunological parameters in the diagnosis of primary hemophagocytic lymphohistiocytosis].
    Zhang J; Wang YN; Wang JS; Wu L; Wei N; Fu L; Gao Z; Chen JH; Pei RJ; Wang Z
    Zhonghua Xue Ye Xue Za Zhi; 2016 Jul; 37(7):565-70. PubMed ID: 27535855
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The role of allogeneic hematopoietic stem cell transplantation and Epstein-Barr virus infection on the treatment for child primary hemophagocytic lymphohistiocytosis patients with X-linked lymphoproliferative disease: A rare case report and family survey study.
    Cui T; Wang Y; Wang J; Zhang J; Gao Z; Wang Z
    Pediatr Transplant; 2020 Jun; 24(4):e13635. PubMed ID: 32011062
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Characterization of Epstein-Barr virus (EBV)-infected cells in EBV-associated hemophagocytic lymphohistiocytosis in two patients with X-linked lymphoproliferative syndrome type 1 and type 2.
    Yang X; Wada T; Imadome K; Nishida N; Mukai T; Fujiwara M; Kawashima H; Kato F; Fujiwara S; Yachie A; Zhao X; Miyawaki T; Kanegane H
    Herpesviridae; 2012 Feb; 3(1):1. PubMed ID: 22325832
    [TBL] [Abstract][Full Text] [Related]  

  • 31. XIAP deficiency: a unique primary immunodeficiency best classified as X-linked familial hemophagocytic lymphohistiocytosis and not as X-linked lymphoproliferative disease.
    Marsh RA; Madden L; Kitchen BJ; Mody R; McClimon B; Jordan MB; Bleesing JJ; Zhang K; Filipovich AH
    Blood; 2010 Aug; 116(7):1079-82. PubMed ID: 20489057
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Distinct interactions of the X-linked lymphoproliferative syndrome gene product SAP with cytoplasmic domains of members of the CD2 receptor family.
    Lewis J; Eiben LJ; Nelson DL; Cohen JI; Nichols KE; Ochs HD; Notarangelo LD; Duckett CS
    Clin Immunol; 2001 Jul; 100(1):15-23. PubMed ID: 11414741
    [TBL] [Abstract][Full Text] [Related]  

  • 33. HHV-8-related hemophagocytic lymphohistiocytosis in a boy with XLP phenotype.
    Pasic S; Cupic M; Lazarevic I
    J Pediatr Hematol Oncol; 2012 Aug; 34(6):467-71. PubMed ID: 22258354
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cerebral Vasculitis in X-linked Lymphoproliferative Disease Cured by Matched Unrelated Cord Blood Transplant.
    Gray PE; O'Brien TA; Wagle M; Tangye SG; Palendira U; Roscioli T; Choo S; Sutton R; Ziegler JB; Frith K
    J Clin Immunol; 2015 Oct; 35(7):604-9. PubMed ID: 26433589
    [TBL] [Abstract][Full Text] [Related]  

  • 35. X-linked lymphoproliferative disease in an adult.
    Hoshino T; Kanegane H; Doki N; Irisawa H; Sakura T; Nojima Y; Miyawaki S; Miyawaki T
    Int J Hematol; 2005 Jul; 82(1):55-8. PubMed ID: 16105760
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Characterization of a novel disease-causing mutation in exon 1 of SH2D1A gene through amplicon sequencing: a case report on HLH.
    Zhou S; Ma H; Gao B; Fang G; Zeng Y; Zhang Q; Qi G
    BMC Med Genet; 2017 Feb; 18(1):15. PubMed ID: 28196537
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Novel Mutations in SH2D1A Gene in X-linked Lymphoproliferative Syndrome, Diagnosed After B-Cell Non-Hodgkin Lymphoma.
    Sharapova SO; Fedorova AS; Pashchenko OE; Vahliarskaya SS; Guryanova IE; Migas AA; Kondratenko IV; Aleinikova OV
    J Pediatr Hematol Oncol; 2017 May; 39(4):e203-e206. PubMed ID: 28267077
    [TBL] [Abstract][Full Text] [Related]  

  • 38. X-Linked Lymphoproliferative Syndrome Presenting as Adult-Onset Multi-Infarct Dementia.
    Blackburn PR; Lin WL; Miller DA; Lorenzo-Betancor O; Edwards ES; Zimmermann MT; Farrugia LP; Freeman WD; Soto AI; Walton RL; Klee EW; Atwal PS; Abraham RS; Billadeau DD; Ross OA; Dickson DW; Meschia JF
    J Neuropathol Exp Neurol; 2019 May; 78(5):460-466. PubMed ID: 30990878
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Simultaneous manifestation of fulminant infectious mononucleosis with haemophagocytic syndrome and B-cell lymphoma in X-linked lymphoproliferative disease.
    Hügle B; Astigarraga I; Henter JI; Porwit-MacDonald A; Meindl A; Schuster V
    Eur J Pediatr; 2007 Jun; 166(6):589-93. PubMed ID: 17058098
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Missense mutations in SH2D1A identified in patients with X-linked lymphoproliferative disease differentially affect the expression and function of SAP.
    Hare NJ; Ma CS; Alvaro F; Nichols KE; Tangye SG
    Int Immunol; 2006 Jul; 18(7):1055-65. PubMed ID: 16720617
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.